| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |